The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ANA trial: Development of a diagnostic test and dynamic evaluation of ctDNA to optimize follow-up and tailor treatment in patients with HPV-related cervical and anal tumors.
 
Renata Bonadio
Consulting or Advisory Role - Ache Company; MSD
Speakers' Bureau - Adium Pharma; AstraZeneca; BMS Brazil; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD; Nestle health science; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD; MSD
 
Camila Venchiarutti Moniz
Honoraria - Libbs
Research Funding - BMS; Immix BioPharma; Jazz Pharmaceuticals; Merck; Servier/Pfizer; Takeda
Travel, Accommodations, Expenses - Libbs; Merck
 
Letícia Leis
No Relationships to Disclose
 
Pedro Hashizume
No Relationships to Disclose
 
Maria Luiza Nogueira Dias Genta
No Relationships to Disclose
 
Raelson Miranda
No Relationships to Disclose
 
Laura Sichero
No Relationships to Disclose
 
Lara Termini
No Relationships to Disclose
 
Maria Aparecida Koike Folgueira
No Relationships to Disclose
 
Paulo Hoff
Leadership - Oncologia D’Or
Stock and Other Ownership Interests - Oncostar
Honoraria - Bayer Health (I); United medical (I)
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (I); EMS; EMS; Exelixis (I); Lilly (I); United Health Group (I)
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BMS Brazil (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Exelixis (Inst); Lilly (I); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Maria Estevez-Diz
No Relationships to Disclose